TEVA position history
The shares of Teva Pharmaceutical Industries (TEVA) that DME Capital Management reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 324,850 shares, $4.6M, 0.21% of portfolio
- 2024 Q2: 324,850 shares, $5.3M, 0.26% of portfolio
- 2024 Q3: 324,850 shares, $5.9M, 0.24% of portfolio
- 2024 Q4: 468,550 shares, $10M, 0.53% of portfolio, Add +44.2%
- 2025 Q1: 568,200 shares, $8.7M, 0.44% of portfolio, Add +21.3%
- 2025 Q2: 3,778,777 shares, $63M, 2.7% of portfolio, Add +565.0%
- 2025 Q3: 3,778,777 shares, $76M, 3.0% of portfolio
- 2025 Q4: 3,058,734 shares, $95M, 3.4% of portfolio, Reduce −19.1%
- 2026 Q1: 2,910,729 shares, $88M, 2.7% of portfolio, Reduce −4.8%
- 2026 Q2: 2,886,059 shares, $98M, 2.5% of portfolio, Reduce −0.8%
- 2026 Q3: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|